- Home
- CPOP vs ICCM Comparison
CPOP vs ICCM Comparison
Compare CPOP & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CPOP | ICCM |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 41.4M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CPOP | ICCM |
|---|---|---|
| Price | $0.31 | $0.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 47.1K | ★ 273.6K |
| Earning Date | 11-17-2025 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $53.39 |
| Revenue Next Year | N/A | $174.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.30 | $0.54 |
| 52 Week High | $2.60 | $1.40 |
Technical Indicators
Market Signals| Indicator | CPOP | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 37.85 | 48.99 |
| Support Level | $0.30 | $0.58 |
| Resistance Level | $0.36 | $0.74 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 20.37 | 29.21 |
Price Performance
Historical ComparisonAbout CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.